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The inner workings of the smallest neural structures have been mysterious in function
since they were discovered. Even more interesting are the modes and methods by which
an internal reaction is waged as a result of an external stimulus. This is especially true if
the stimulus is not inherently or physically painful or harmful, but rather emotional.
Stress, for example has a major deleterious effect on the brain. However, exactly how
different brain regions work together to react to stress is largely unknown. The primary
goal of this study was to further understand how neurons within the topography of the
paraventricular nucleus (PVN) and supraoptic nucleus (SON) ofthe brain's hypothala-
mus are altered during the whole-organism stress response. A significant proportion of
PVN and SON cells are made up of nitric oxide (NO) synthase (NOS)-containing neu
rons. Previous studies have shown that a single acute restraint paradigm differentially ac
tivates NO-producing endogenous machinery within these hypothalamic areas. However,
the temporal activation profile ofrestraint-induced NOS reactivity within the PVN and
SON remains to be clearly determined. In this study, several techniques were used in
cluding the following: nicotinamide adenine dinucleotide phosphate diaphorase
(NADPH-d, a histochemical NOS index), im- munohistochemistry for Fos, caspase acti
vated DNAase (CAD, an enzyme that cleaves chromosomal DNA in apoptotic cells), and
phosphorylated extracellular signal-regulated kinase (pERKl/2; a signaling pathway
preferentially activated in response to growth factors and regulator of cell proliferation
and differentiation). We have analyzed the pattern of this neural activation in response to
stress in adult male Wistar rats in the SON and PVN after the animals were placed in a
restraint device for one-, three- or six- hours and compared the results to those ofunre
strained rats. The aim was to determine the temporal profile of restraint-induced activa
tion ofthe NO production machinery within the SON and PVN. As Recruitment ofneu-
ronal pools is a well-recognized concept of the function of hypothalamic neurons. The
present observations suggest a progressive recruitment of nitrergic neurons within these
neuronal domains during whole animal exposure to stress. In sum, the data from the pre
sent observations extend our understanding of the discrete temporal reorganization ofthe
PVN and SON and their involvement in signal processing during the stress response.
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Almost no one is immune to emotional stress. Certainly, the brain is the first line
of defense in stressful situations. Acute restraint stress has been exhibited to activate a
distinct system of brain substrata within a neural signal-response circuit. This emotional
type of stress recruits the participation of certain brain areas. Functional neuroanatom-
ical circuits are created when concurrent harmonious modifications in neuronal activity
traverse multiple regions of the brain. Acute restraint stress is known to inflict changes
upon the brain and inhibition of movement elicits panic and anxiety in rats.18 Alterations
in metabolism, functional or both occur in a number of neurotransmitter pathways when
a stressful treatment is introduced. Simultaneously, there is a temporal dimension and
region-specific activity as a result of stress. 38,46,57,72,97,117 y[my different neuronal path
ways can be activated by the stress response. Stress elicits immediate reactions from
the nervous and endocrine systems. It disrupts the body's homeostatic condition, which
causes an adjustment in an effort to regain homeostasis.32'37-71'102'107
One neural cellular transmitter known to play a major role in the stress reaction is
Nitric Oxide (NO), a signaling molecule that is formed from L-arginine and oxygen and
whose synthesis is modulated by the enzyme NO synthase (NOS). NO is a gas and free
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radical and is likely concerned with modulating neuronal processes and regulating the
function of neurons.74 NOS associated with brain functions is referred to as neuronal
NOS, or nNOS. Stress by restraint increases nNOS in several brain areas.71 These ar
eas are known to be incorporated with the autonomic nervous system and so it is possible
that NO is actually regulating sympathetic output to the periphery either directly or indi
rectly. 1.64,71,87,92
NO is a neurotransmitter modulator and may be implicated in regulating excitability
and firing, long-term potentiation (LTP), and long-term depression (LTD). In this study,
we also studied the presence of Fos, a proto-oncogene and indicator of neuronal acti
vation. Colocalization of Fos and nNOS may indicate that stress-activated neurons that
form pathways within the hypothalamus and mediate the stress response may utilize NO
as their neurotransmitter molecule. Through research, our understanding of the discrete
spatio-temporal configuration of the paraventricular nuclear (PVN) and supraoptic nu
clear (SON) nitrergic domain and its contribution to signal processing during the stress
response has been improved.77'86'92
1.1 Background and significance
The neuromodulator NO is produced by NO synthase (NOS) and is now readily ac
cepted as an important regulator of many brain functions including stress mechanisms
and pathways.64 In the hypothalamus, there are two particular neuronal systems that are
regulators of autonomic function including the reaction to stress. The PVN and SON con
tain a rich population of NOS neurons and fibers which have been reported to mediate
the stress response.10>105 While much is known of the PVN and SON nitrergic system,
not much is known regarding the adjustment of the hypothalamic nitrergic system fol
lowing progressive exposure to acute stress. It is anticipated that by augmenting an emer
gent understanding of the neurobiological mechanisms that form the basis of the stress
response, researchers and clinicians in this area of study and beyond will further progress
en route to the goal of detecting, treating, and handling individuals with stress-related
biopsychopathologies. 10«64'105
Stress-activated immediate early gene expression in the PVN and SON is thought to
affect several stress-induced autonomic and behavioral responses. However, the possibil
ity exists that within these areas, restraint stress exerts its effect primarily by directly ac
tivating NOS-producing neurons. NO may be mediating the effects of the restraint-stress
spatio-temporally. If this is true then the expectation would be that there would be an in
crease in endogenous NOS production and activation of Fos. Also, the prediction is that
there will be an increase in the proportion of co-localization as evidenced by the observa
tion of NOS-producing neurons expressing Fos.9'33'42'108
In order to bring validation to our assumptions, we have used several methods. For
example: histochemistry for nicotinamide adenine dinucleotide phosphate-diaphorase
(NADPH-d) as a cytochemical NOS indicator; immunohistochemistry to detect neuronal
nNOS protein; and immunohistochemistry for Fos. Although exposure to stress elicits
an immediate activation of discrete response pathways, sustained exposure of an acute
stressor may presumably result in the proliferation or death of cells in these brain areas.
It is not clearly understood how the balance between cell proliferation/differentiation
and apoptosis is affected by a prolonged, single episode of stress exposure. To further
grasp the cellular mechanisms underlying stress-induced cellular activation, this study
has also compared immunohistochemical mapping of differential expression of caspase
activated DNAase (CAD), an apoptotic cell indicator; and phosphorylated extracellular
signal-regulated kinase (pERKl/2).
1.2 Research questions
The objective of this investigation was to determine activity patterns in neurons
of the rat hypothalamic PVN and SON after the application of restraint-induced stress.
Therefore, we have investigated this expression in adult male Wistar rats subjected to 1,
3, or 6 hrs of restraint (and killed immediately after the restraint period). Control animals
were left in their home cages. This project aimed to reveal neuronal differences in the
spatio-temporal expression of NOS in the PVN and SON. The findings of the proposed
study were anticipated to reveal that NO-producing neurons in these nuclei are differen
tially expressed according to successively increasing incremental time frames of sustained
exposure to an acute stress episode. Additionally, proliferation/differentiation and apop-
tosis rate changes will also be observed to reveal a clearer picture of the stress-related
reorganization. Specifically, it remains to be determined if sustained acute stress exposure
caused cell differentiation in these nuclei.
1.2.1 Conceptual/Theoretical Framework
The objective of this investigation was to determine the localization of changes in
the neurons of the rat PVN and SON after the application of restraint-induced stress that
may indicate alterations in activity. We will investigate the expression of NOS in these
hypothalamic subregions of male adult Wistar rats subjected to 1, 3, or 6 hrs of restraint.
Control animals will be left in their home cages. This project aims to reveal nitrergic neu
rons by using histochemical processing for NADPH-d over this time period. The study
will investigate the spatio-temporal expression of NOS. The findings of the proposed
study have revealed that nitric oxide (NO)-producing neurons in these nuclei are differ
entially expressed in rats during a sustained exposure to an acute stress episode. The goal
of identifying the putative appropriated neural circuits involved in the spatio-temporal
stress response is the ultimate objective and this work is aimed at solving one small piece
of the larger puzzle.
1.2.2 Specific aims/Hypotheses
Specific Aim 1
To investigate the distribution of NO-producing neurons in the hypothalamic PVN and
SON of adult male rats over a time-course of restraint.
Hypothesis 1
The pattern of spatio-temporal distribution of NOS-positive neurons within the PVN and
SON will show a distinct pattern of activation over time, consistent with a functional reor
ganization of the NO-producing system.
Specific Aim 2
Determine the pattern of stress induced NOS and fos staining in the hypothalamic SON
and PVN.
Hypothesis 2
The pattern of Fos and NOS colocazation within PVN and SON will exhibit time-
dependent variation following progressive exposure to acute stress.
CHAPTER 2
REVIEW OF LITERATURE
Stress can be defined as any physical or physiological modification that results in an
interruption of the bodyaAZs homeostatic activity.5 Stress generally elicits an interaction
of neuronal and endocrine systems that produce glucocorticoids (stress hormones). These
glucocorticoids stimulate physiological changes to adjust to acute stress, such as catabo-
lizing lipids and proteins, decreasing inflammation, and metabolizing glucose.5-57-100
There are two basic types of stress: acute and chronic. Chronic stress results from
repeated exposure to a stimulus over a period of time and acute stress, which we will
explore here, is imposed by a one-time stressor. Our focus on acute stress as opposed to
chronic stress is rooted in the tendency for chronic stress to provoke adaptive responses,
which are apt to dampen its effect. It is important to note that there are no real a\AIJstress
receptorsaAI in the brain that are only activated in times of extreme or acute stress.
Rather, the responses that have been observed as reactions to stress are ever-present.
However, there are thresholds that, when exceeded, cause a reaction that is considered to
be a stress response.3-111 There is a strong body of knowledge available in literature about
the hypothalamic subregions in stress-causing situations in rats. The hypothalamus is a
very important participant in the stress response. Its circuitry communicates with many
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other brain areas including the pituitary, which is responsible for the release of several im
portant hormones. In previous studies, an increase of activity in this area during stress has
been observed.22'66'73'75'99 To discover the neural substrates involved in the restraint stress
response, we will use expression of NADPH-d, immunohistochemistry for Fos, CAD, and
pERKl/2 as indicators for neuron activity. We will analyze the pattern of this neural acti
vation and relate the findings to the time frame of the experiment.
2.1 Nitric Oxide
NO is a signaling molecule formed, in the presence of NADPH and oxygen, from L-
arginine and oxygen. The synthesis of NO is modulated by NOS, a catalytic enzyme. The
reaction also produces L-citrulline. In fact, NO is made by the conversion of L-arginine
to L-citrulline. NO is a gas and free radical that is likely concerned with the modulation
of certain neural processes. Its formulation is made possible via the oxygenation of L-
arginine by NOS. There is an ever-growing source of literature about the significance of
NO, which is a gaseous transmitter in the central nervous SyStem.8'17'55'62'71'87'103 Nitro-
glycerin and other indirect donors of NO have been in use as a treatment for those suffer
ing from heart attacks. This is because they have vasodilatory effects. NO was found to be
the substance diffusing through vessel walls and causing vasodilation. It has been previ
ously called aAIJendothelium-derived relaxing factoraAI (EDRF). NO only has a half-life
of milliseconds. After it forms it diffuses to bind to its targets. Its most common target is
the soluble guanylate cyclase (sGC). 12,39,54,56,71,80,90
NO does not accumulate in vesicles as other common neurotransmitters. Others are
packaged into the small sacs and are released from these vesicles into the synapse, the
small space between neurons. Next the cell receiving the signal is activated by this neu-
rotransmitter. NO, on the other hand, is atypical and is not stored in this way. It is synthe
sized at the site and the time that there is a need for it. It is thought to just diffuse from the
cell that produced it to close-by cells. NO is also different from other neurotransmitters
in that it does not need membrane receptors to mediate its action. Most neurotransmitters
consist of a string of peptides or amino acids, which are coupled with matching receptors
on the cell surface. However, NO is more promiscuous and requires no receptor, rather,
it passes through membranes directly. Also, NO can act retrogradely, that is from postsy-
naptic terminals to presynaptic terminals. One of the tiniest and lightest molecules known
to be a biological messenger in the mammalian body, it is also the first known gas to act
as such a messenger.29'71 So novel was NO in its infancy of discovery, that it was awarded
the recognition of being named Science's aAIJMolecule of the YearaAI in 1992. Among
its many interesting qualities, it is a very versatile molecule. It is a noxious chemical in
the atmosphere and it exists in small amounts in the body, and it is known to have many
benefits.2'63
NO is very interesting to study because it is so unique. However different, it does
have some similarities to other neurotransmitters. For example, in normal males, nerves
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in the pelvis receive impulses from the brain during sexual excitement. These pelvic
nerves then make and release NO, which causes the vessels in the penis to dilate and there
is a rush of blood into the penis, which causes an erection. If NO is blocked, the penis
does not become erect. This cascade of events is similar to that of other neurotransmit-
ters. Also, when food is being digested, the gut begins rhythmic movements to move the
food along. NO is what causes the relaxation portion. Also, some babies have a condi
tion called infantile hypertrophic pyloric stenosis, in which this rhythmic movement is
impaired. This illness is commonly ascribed to a lack of NO.4>29>65>115
2.2 Nitric Oxide Synthase
The production of NO requires several cofactors one of which is heme. Heme is a
compound that contains iron (Fe2+) ions and carries oxygen and also makes blood red.
Heme is known to be an electron acceptor.29'91 Along with tetrahydrobiopterin (BH4),
and calmodulin (CaM), heme is needed for the complete functionality of NOS. There are
binding sites for NOS on all of these. NOS is homodimeric and it is divided into two do
mains: an oxygenase and a reductase domain. Flavin adenine dinucleotide (FAD) and
flavin mononucleotide (FMN) are located in the reductase domain. The five electrons that
are transferred from NADPH are transferred in sequence to FAD and FMN. The oxyge
nase domain of NOS is where L-arginine binds and its guanidine group is the last electron
acceptor. In the presence of oxygen, the intermediate ML'-hydroxy-arginine is formed
by this reaction. The post synaptic density protein ((PSD95), with Drosophila disc large
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tumor suppressor (Dlgl), and zonula occludens-1 protein (zo-1)) (PDZ)20 domain for
nNOS is close to the C-terminus and binds to the PDZ domain of postsynaptic density
(PSD) and related to proteins like PSD-95 (a PDZ-PDZ interaction).40-51'71-82
More efficient nNOS activation is achieved by the subsequent binding of PSD-95 to
AT-methyl-D-aspartate (NMDA) receptors. The PSD-95 scaffolding protein and also the
assembly of a ternary complex are required in order for the physical interaction of nNOS
with NMDA receptors to take place. Also, PSD-95 can reinforce its binding to mem
branes via Af-terminal palmitoylation. In contrast to the previously mentioned membrane
association, a NOS-PDZ interaction with C-terminus carboxy-terminal PDZ ligand of
nNOS (CAPON) may compete with PSD-95 to bind. This relocates the activity of NOS
in the cytosol and the nNOS may also be regulated by a novel aAIJprotein inhibitor of
nNOS.aAi or a PIN. Once the ternary complex is formed, it is invaluable to the competent
coupling Ca2+ influx (by way of NMDA receptors) to nNOS activity. nNOS has corre
spondingly been shown to be subjected to posttranscriptional modifications, like phospho-
rylation. The catalytic activity of nNOS can be influenced by these modifications.8"24'68'71
Along with the aforementioned nNOS, involved in processing neuronal information,
there are also two other isoforms of NOS. Epithelial NOS (eNOS) is found in the cells of
layered membranous tissue and has a role in regulating vasodilatation and inducible NOS
(iNOS), also called inducible NOS or macrophagical NOS, is activated in immune reac-
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tions and is therefore not constitutively active.83'110 Whereas nNOS and eNOS are consti
tutively activated and are controlled by calcium (Ca2+) ions; iNOS is Ca2+ independent
and its activity is controlled by cytokines. nNOS activation, as stated, is mainly regulated
by an increase in intracellular Ca2+. This increase activates nNOS through calmodulin
(CaM) binding. nNOS activity in neurons is specially coupled to Ca2+ influx through N-
methyl-D-aspartate (NMDA)-type glutamate receptors. These are receptor channels that
are tethered to CaM. When stimulated by glutamate, nNOS neurons, synthesize NO. The
NO modulates synaptic transmission and plasticity. S'10.44-92'98
As indicated, NO can be a(n) retrograde and/or anterograde transmitter depending
on from where it is released. If it is released from the soma, it acts as a retrograde trans
mitter. When released from the nerve terminals, it acts as an anterograde transmitter. The
induction of corticostriatal long-term depression from striatal spiny neurons owes much
of its function to the NO-cyclic guanosine monophosphate (cGMP) pathway. As a neu-
rotransmitter, NO stimulates sGC activity and cGMP synthesis in NO receptive neurons.
In many cells, NO proliferates the cGMP concentration by activating sGC. 16>41>51-113 In
nNOS, a 10.5 kb mRNA tnjislates into a protein which is about 155 kD. Though ex
pressed constitutively; it might be regulated by transcription factors like AP-2 (activator
protein-2, critical for embryogenesis), TEF-1/MCBF (simian virus 40 transcription en
hancer factor/M-CAT-binding factor, activates the gene promoters in muscle cells), and
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CREB/ATF/Fos (c-AMP response binding element/activating transcription factors). Its
expression may also be regulated by glucocorticoids at the mRNA level in vivo.71'118 The
promoter region of NOS does not have a consensus sequence for glucocorticoids so the
exact way that it acts is not clearly understood. For example, nNOS which was previ
ously thought of as a cytosolic enzyme, is now believed to be able to bind to membrane
receptors via proteins that have PDZ domains, which aid in binding together signaling
complexes and in affixing transmembrane proteins to the cytoskeleton. The PDZ motifs
allow submembranous signaling molecules to cluster. These PDZ motifs are sequences
that have about 90 amino acids involved in protein-protein interactions. 15.7°.71.84>101
2.3 NO and the Hypothalamus
Histochemistry for NADPH-d and nNOS immunohistochemistry have shown the
presence of NO-producing neurons in several areas of the vertebrate central nervous sys
tem. For the rat, the dispersal of nNOS positive cells has been meticulously shown in hy-
pothalamic and limbic nuclei implicated in the modulation of reproductive behavior. Two
of these areas are PVN and the SON.no The PVN of the hypothalamus, an effector nu
cleus, plays a central role in the commencement and coordination of the autonomic stress
response and is made up of at least eight cellular subdivisions including the magnocellu-
lar and parvocellular subdivisions. Its significance in the preservation of homeostasis and
adaptation to stressful stimuli is very important. Once the parvocellular cells of the PVN
are activated, many neuropeptides including corticotropin releasing hormone (CRH) or
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corticotropin releasing factor (CRF) are released.6'71'110'119 The SON and PVN are known
to secrete vasopressin and oxytocin and they also modulate the cardiovascular and neu-
roendocrine systems and sympathetic function. These areas are also activated in times of
stress and by this, increase the amount of vasopressin and oxytocin. NO has been reported
to regulate the function of neurons in the PVN and SON. 13>58'74.93'112
The hypothalamus is a part of the hypothalamic pituitary adrenal (HPA) axis, a
stress-reaction neural pathway. The activation of the HPA axis is an indication that stress
response mechanisms have been set into motion. Stressful stimuli are known to initi
ate the transcription of NOS with a resultant increase in nitrergic activity in the HPA
axis.47 This suggests that the regulation of stress hormones adrenocorticotropic hor
mone (ACTH) and corticosterone may be under the control of NO. The down-regulation
of NOS transcription is accomplished with a feedback mechanism and is a function of
glucocorticoids.71 In this context, the general adaptation syndrome (GAS) is the process
by which animals generally react to stress and the central component of GAS is the HPA
axis. HPA axis regulation includes three processes that are interconnected: diurnal rhythm
maintenance, stress or threat reaction/response activation, and using negative feedback
mechanisms to reestablish basal activity.31 The specific and intricate ways in with the
HPA system works has yet to be elucidated.25'26'64'71'95'114 Functional ailments and mood
disorders have a basis in the HPA axis and this is the reason that antidepressants, which
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regulate the function of the axis, are used to treat these disorders. Problems with this axis
are responsible for such conditions as bipolar and anxiety disorder, attention deficit with
hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), and major depres
sive disorder. In sum, NO activation is associated with stimuli that increase sympathetic
activity.61-85-104
2.4 Fos and the Hypothalamus
Fos, the protein consequential yield of thefos protooncogene, tends to accumulate
in the nucleus of active neurons. It is often used to detect activated neurons. An imme
diate early gene (EEG), Fos is a transcription factor that is believed to mediate long-term
modifications of neural functioning. After it is formed the Fos protein is transported to
the nucleus, where it interacts with another IEG product called Jun (product of c-jun
proto-oncogene) by dimerization. The interaction of Jun and the Fos protein creates a het-
erodimeric transcription factor that regulates aAIJdownstreamaAJ. late response gene ex
pression. The activator protein 1 complex (AP-1) (the Fos/Jun dimer) is a transcriptional
modulator. The regulation of cell proliferation, differentiation, apoptosis, and also bone
metabolism fall under the sphere of AP-1. Novel experiences can cause increased Fos ex
pression. Some examples include restraint, new cage introduction, shock to the foot, and
first epinephrine injection. iU4,33,35,36,50,52,69,74,8i,94
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The way in which neurons tend to react to extracellular stimulation is by altering
the expression of specific immediate-early genes. Fos, evoked by influxes of calcium that
ensue from cell excitation, is commonly used as a marker for neuronal activation. Fos,
as it is an inducible transcription factor, is among the initial proteins to materialize. The
quickness in which increases appear, and histological techniques that allow for discovery
at the cellular level, are hallmarks that have led to their broad use in the identification of
neurons that are activated. This detection of activity using Fos is possible partly because
it does not require the production of new protein. Also,Fos has a high replacement rate
for the protein product. All of these factors lead to Fos protein accumulation being a very
good neuronal activity indicator. 23,30,36,52,96,116
In many different types of cellular responses, the manifestation of a comparatively
modest set of standard primary response genes is often elicited. This solicitation can be
from varied sources including but not limited to neurotransmitters and growth factors.
This is what occurs in the case of Fos. The accumulation of Fos protein can happen trans-
synaptically, so it is possible to identify functionally related neurons at many stages along
neural pathways of interest. While the extended period of Fos protein accumulation pre
cludes the possibility of identifying sequential synaptic connections based on temporal
dissection, as is done with viral vector tracing techniques, the advantage of Fos localiza
tion is the ability to visualize neurons that are specifically activated by a particular stimu-
17
1US.35'48'52
2.5 pERKl/2 and CAD and the Hypothalamus
Extracellular signal-regulated kinase (ERK), which is a classical mitogen-activated
protein kinase (MAPK), is associated with the control of targets and receptors on the cell
membrane. For the purposes of this study, we will use the term ERK, which refers to a
specific division of the MAPK family in mammals. Many cellular functions as diverse
as terminal differentiation, apoptosis, and cell proliferation, are all directly influenced
by activation of the ERK pathway. ERK1 and ERK2 are often together referred to as
ERK1/2, sharing 83 percent homology. Particularly of interest is pERKl/2 (or phospho-
rylated MAPK3 and MAPK1) because it regulates cell proliferation and differentiation
and is involved in a signaling pathway that is favorably initiated in reaction to growth fac
tors. 21,28,67,88,89,106,109 pERKi/2 is activated by MEK (MAP kinase or ERK kinase), its
upstream kinase, by phosphorylation. In the presence of growth hormones, carcinogens,
other transforming agents, and psychological stress, Ras (GTPase bound to the mem
brane) is activated. Once this happens, c-Raf is subsequently activated. Then it, in turn,
activates MKK (MAP kinase kinase), MEK, or MAP2K by phosphorylation, which cre
ates pERKl/2. pERKl/2 is then translocated to the nucleus, where it activates the needed
transcription factors. When stressful stimuli cause a disruption of homeostasis, many sys
tems in the body react; however, the neuroendocrine system is among the earliest. Follow
ing acute restraint stress, concentrations of pERK have been shown to increase in the hy-
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pothalamus, amygdala, dorsal raphe, cingulate and prefrontal cortices, and hippocampus,
which are some of the most important brain structures involved in the response to stress.
Long-term potentiation (LTP), central excitatory transmission over synapses, is vitally
necessary for learning and the formation of memories. 19,28,43,49,59,60,79,88,89,109,120 ERK
has a central role in LTP and this has been shown in several brain areas including, but
not limited to, the hippocampus, the amygdala, insula, and synaptic regions between the
amygdala and the thalamus. During synaptic plasticity, structural or functional changes
occur in the connections of neurons. The activation of ERK1/2 modulates gene expression
and thereby helps to mediate LTP and contributes to synaptic plasticity.7-28'34'53'76'78 We
argue that this is essential for the spatial-temporal neuronal re-organization that occurs as
a result of restraint stress.
There is an extensive body of literature investigating stress in general. However,
more research is needed on stress as it relates to the spatio-temporal interactions between
specific subregions of the hypothalamus as a result of acute stress in rats. This investi
gation attempts to study neural activation involved in hypothalamic nucleic synergy in
the stress response. Also, because the way in which the balance linking cell prolifera
tion/differentiation and apoptosis is affected by a single episode of stress exposure has yet
to be clearly elucidated, we also aim to expound on this. We will use Fos expression as
one of the indicators for neuron activity and analyze the pattern of this neural activation
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in response to stress. Fluorescence as well as bright-field immune reactivity will be an
alyzed for NOS, Fos, pERKl/2, and CAD. We plan to illuminate these relationships by
using stress by restraint. It is our expectation that this study will lead the possibility of in




3.1 Design of the study
Six-week old Male Wistar strain rats were used for the present study. The weights
for the animals were between 250 and 485 grams. The animals were grouped into one of
four groups: unrestrained; restrained for 1, 3, or 6 hours.
3.2 Description of the setting, sampling procedures, description of the instruments
The restraint was achieved by wrapping a cylindrical but flexible metal gauze closed
at both ends with plexi glass cups to act as a rodent restrainer. At the end of the observa
tion, the rats were anesthetized with Avertin. The animals were cared for per the More-
house School of Medicine Internal Animal Care and Use Committee (IACUC) regula
tions. They were housed in a climate controlled environment. Regular light cycles of 12
hour on/12 hour off light/dark were used. Provisions were made for observation of the
animals at appropriate intervals. Food and water were provided ad libitum.
3.2.1 Transcardial Perfusion
To prepare the sacrificed rats for infusion, they were be taken from the transport
container individually and injected with an anesthetic then placed back into the trans
port container to allow for anesthetic potency to take effect. The analgesic efficiently
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processed through the rats' nervous system to rapidly and severely decrease activity.
The infusion pump was prepared with two 1L glass narrow-necked laboratory bottles -
one containing phosphate-buffered saline (PBS) and the other containing four percent
paraformaldehyde (PFA) fixative in 0.1M PBS. Controlled release of a valve allowed
PBS to flow through a tube into an attached hypodermic needle that was connected to
the infusion pump. This pump was used to thoroughly infuse the circulatory system with
PFA. The animals were then decapitated and the brain tissue was harvested and post fixed
overnight at 4Af°C followed by immersion in 30 percent sucrose until sectioned.
3.2.2 Brain sectioning
Each brain was mounted on a removable cryostat platform. Tissue-Tek® Optimum
cutting temperature (O.C.T.) formulation embedding medium (Sakura Fineteck USA,
Inc., Torrance, CA 90501 USA) for frozen tissue specimen was used to ensure most fa
vorable sectioning environment, to add additional firmness, and to preserve the struc
ture and shape of the brain tissue to facilitate the cutting process. At room temperature,
a small amount of Tissue-Tec was placed on the cryostat (Micron International, HM 500
OM) platform. A thin layer of Tissue-Tec was then placed on all exposed surfaces of the
brain forming a thin layer encapsulating the entire brain. The brain/Tissue-Tek complex
was placed in an auxiliary holding corridor inside of the cryostat and allowed to freeze to
a box temperature of about -20Af°C. Once this temperature is was reached, the platform
with the brain attached was placed in the main cryostat corridor. The brains were cut in
22
the coronal plane in an anterior to posterior direction into sections twenty (20) microns
thick. The sections were collected in 24-well plates containing 0.1M phosphate buffered
saline (PBS, pH 7.4) then removed and placed in crypprotectant at -20Af°C until further
tissue processing is preformed.
3.3 Data collection procedures
3.3.1 NADPH-d Studies
Once prepared by washing with phosphate buffer, every tenth section was collected
as floating sections and stained with NADPH-d (incubated in 0.1M PBS, pH 7.4, contain
ing 0.3 percent Triton X-100, 0.1 mg/ml nitroblue tetrazolium and 1.0 mg/ml NADPH)
overnight in an incubator at 37Af°C to visualize NOS, which was used to give a mea
sure of the stress response. The sections were then washed for 15 minutes (3 times for 5
minutes each) in PBS and mounted on gelatin-subbed microscope slides using the free-
floating tissue mounting method. The sections were allowed to dry overnight in a slide
drawer. Dehydration and clearing was then accomplished using gradients of alcohol. Per-
mountSDc mounting medium was used to cover slip the slides.
3.3.2 Immunofluorescence Studies
The sections were washed 3 times for 10 minutes each in 0.03 percent Triton X
mixed with PBS. Blocking was then performed with 10 percent serum (5 percent goat
serum, 5 percent donkey serum) for 1 hour at room temperature. After this incubation, the
sections were double-labeled for Fos and NOS. To accomplish this, the sections were in-
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cubated in the primary antibodies (mouse anti-NOS diluted l,000x in 10 percent serum
(Sigma N2280 037K4765 Monoclonal Anti-Nitric Oxide Synthase, Brain 1-181 An
tibody) and rabbit anti-Fos diluted 5,000x in 10 percent serum (Rabbit Polyclonal to
Fos ab 7963-1 Lot No. 25192) for 72 hours. The sections were then rinsed 3 times in
0.03 percent Triton X for 10 minutes each. All subsequent steps were preformed in a
dark room. The sections were then incubated in the secondary antibodies (Texas Red
(TRTTC)conjugated affinity purified anti-mouse IgG (H&L) Goat, Rockland 610-1902,
Lot No. 22677 and Fluorescien (FITC) conjugated affinity purified anti-rabbit IgG (H &
L), donkey, Rockland Code No. 611-702, Lot No. 19484) diluted in 10 percent serum.
They were then rinsed again 3 times 10 minutes each. Floating sections were used to
mount slides which were then coverslipped. For pERKl/2 and CAD assays FITC and
TRITC were used respectively in the manner above. Analysis was achieved using a Nikon
camera and NIS Elements software.
3.4 Statistical analysis
Analyses was preformed using a Nikon microscope fitted with the appropriate cam
eras and Nikon Imaging Software (NIS) Elements. The target neurons were counted man
ually (using the aid of placeholder markers included with the software) and statistical
study was carried out with Microsoft Excel and Graphpad using One-way analysis of
Variance (ANOVA) and/or t tests followed by Bonferroni Dunn. p<0.05 was used to re
ject the Null hypothesis.
CHAPTER 4
RESULTS
4.1 NOS/NADPH-d Neuron Detection
To determine whether there was any correlation between restraint stress and an in
crease in the presence of nNOS-positive neurons in the SON and PVN, both hypothalamic
nuclei, we performed enzymatic tests for the presence of NADPH-d, a known indicator of
NOS. It was observed that in the SON (FIG A.3) NOS expression increased over two and
a half times that of the control animals (FIG A.4). In the PVN (FIG A.5) the number of
NOS-expressing cells increased over 6-fold. These results confirm previous findings that
stress does indeed change NOS activity in the hypothalamus.
Although NADPH-d's presence gives a very clear representation of NOS, it was
deemed necessary to examine whether this change patter will be reflected in the staining
for nNOS. It has been severally reported that the diaphorase signal can indicate the pres
ence of other types of NOS. So to confirm what we observed in our NADPH-d results, we
repeated the experiment using histochemistry with immunofluorescence in conjunction
with antibodies specific to nNOS
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4.2 nNOS-immunoreactive Neuron Detection (Immunofiuorescence)
The results showed a 2.45-fold increase in the number of cells expressing nNOS
after restraint stress exposure than in the control animals in the SON. In the PVN, the in
crease was also significant with almost 4 times the neurons observed in the control. This
suggests that the nNOS isoform may account for the diaphorase activity observed in the
PVN and SON. (FIG A.6).
4.3 Determining Spatio-Temporal Effect on NOS/NADPH-d-positive Neurons
In FIG A.7, the differential pattern of NADPH-d in the PVN and SON over the du
ration of the experiment was determined. This was to determine whether the increased
the amount of time that the animal was under stress corresponded to an increase in NOS-
producing neurons. As indicated by the presence of NADPH-d, in the SON and PVN of
animals restrained for 1-, 3-, and 6-hrs were compared with that in control animals left in
their home cages.
This observation yielded several interesting findings (FIG A.7). It was observed
that 3 hrs of restraint caused a 3.5-fold increase in the number of NOS-positive cells in
the SON compared to control animals, a 12% increase in NADPH-d-positive neurons
than was observed in the 1-hr group (FIG A.8). In the PVN, times the number of NOS-
producing cells present in the 1-hr group was observed (FIG A.9). Compared to controls,
the average numbers of cells per section increased significantly. The 6-hr restraint pro-
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duced somewhat different effects in the SON and PVN.
In the SON, for the 6-hr group, the number of NADPH-d-positive cells was not
significantly higher than controls and was actually 58.46% lower compared to the 3-hr
group. Six hrs of stress also produced changes in NOS-positive cell numbers in the PVN.
Here the number fell by 66.67%, when compared with controls and were 98.93% lower
than animals stressed for 3 hrs.
4.4 Spatio-Temporal Effects on nNOS-immunoreactive Neurons (Immunofluorescence)
Taking this into consideration, again, it was prudent to perform another series of
tests with different time periods using immunofluorescence. So the number of cells pro
ducing nNOS in the SON and PVN were counted of animals placed under restraint for 1-,
3-, and 6-hrs with control animals remaining unrestrained as before. Please refer to FIGS:
A. 10 & A. 12). These are graphical representations of the mean number of immunoreac-
tive neurons per section of the SON and PVN, respectively.
The top whisker for each time period represents the maximum in the set. The bot
tom whisker represents the minimum. The top line of the open box outlined in red repre
sents the 3rd quartile of the observation set (75th percentile). The middle line is the me
dian (50th percentile) and the bottom line is the 1st quartile (25th percentile). The bottom
whisker represents the minimum. The black dot represents the mean. Using this system, it
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can be seen that there were 3.5 times more NOS-positive cells in the 3-hr group compared
to controls in the SON. This number was 42.68% higher than the animals restrained for 1
hr. After 6 hrs, there was a 2.78-fold increase in neurons containing nNOS compared to
controls, going from a mean of 29.2 neurons per section to 81.1.
The PVN exhibited similar, but more pronounced changes (FIG. A. 12). The nNOS-
immunoreactive neurons increased 23.89 times. This is a 6.17-fold increase from the 1-hr
time period. These neurons decreased by 88.93% compared to the controls and decreased
by 99.54% compared to the 3-hr animals.
4.4.1 Immunohistochemistry for NOS-Fos, nNOS Co-Localization
To gather more insight into the activity during stress, the immunoflorescence exper
iment also included an antibody aganist Fos to distinguish cellular activity. The number
of SON and PVN cells observed to be positive for Fos were counted on the same sections
used or nNOS (TABLE A.1 and A.2). For visual representations, please see FIGS: A. 15,
A. 16, A. 14, A.20, A. 17, A. 19, A. 18, A. 12, A. 10.
In the PVN, there is a sharp increase in co-localization at the 1-hr mark, but this is
still a very small amount, when compared to the pattern found in the SON, in which the
number of cells exhibiting co-localization of nNOS and Fos doubles at 1 hr from the con
trol. After decreasing 55.86% at 3 hrs, the number of cells increased by 2-fold at 6 hrs.
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For the PVN, after an increase at 1 hr of restraint, the observed co-localization remains
low through the 6th hr.
4.4.2 NOS- pERKl/2-, and CAD-immunoreactivity
In the SON and PVN, pERKl/2 staining (FIG.A.22 shown in green (FITC)) was
most plentiful after restraint for 3 hrs. There was no corresponding change in number
of immunoreactive neurons for CAD (shown in red (TRITC)). Other areas in which
pERKl/2 was noted include the hippocampus (FIG.A.23). Here, our observations suggest
that pERKl/2 is increased in each time period compared to control animals. In the amyg
dala (FIG.A.24), there is a decrease in pERKl/2 immunoreactive cells in the 1-hr and 3hr
groups compared to control and in increase in the 6-hr group. In the sensory-motor cor
tex (FIG.A.25), there is pERKl/2 immunoreactivity in the sensory portion but not in the
motor area.
There is also noted pERKl/2 immunoreactivity in the cingulate cortex (FIG.A.26).
With higher magnification in this area,individual neural cell bodies as well as
fibers/processes displaying pERKl/2 immunoreactivity were also observed. Increased
staining was also observed in the SON with increased times of immobilization. An in




Elucidation regarding the configuration of nNOS expression in the PVN and SON
will aid in understanding the entire stress-response archetype. Studying the nature of this
pattern is important in the overall explanation of the stress reaction. The results of the
present study suggest that when placed under stress by restraint, rats exhibit a distinct pat
tern of activity within the hypothalamus and other discrete brain areas associated with the
organismal response to stress. In the SON, the staining of NADPH-d increased after 1 hr
of restraint, reaching a significant upsurge after 3 hrs. After this time, a marked increase
in staining was evident, however activity decreased sharply after the 6th hr of restraint
stress.
In the PVN, a 3-hr acute restraint stress session is sufficient to cause a significant
shift in the activity gradient across the nuclear region. NADPH-d staining can be seen in
PVN neurons at basal levels, although the positive neurons were less concentrated than in
the SON. There was a marked increase in NADPH-d staining after 3 hrs and a decrease
in activity after 6 hrs. At this point, the NADPH-d staining was not much different from
that observed in control animals. The present observations extend our understanding of
the discrete temporal reorganization of the PVN and SON nitrergic domains and their
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involvement in signal processing during stress exposure.
The present findings suggest that the critical time-point for the maximum increase in
nNOS in the PVN is 3 hrs following restraint exposure. Three hrs of restraint may seem
excessive, however considering real-life situations, it is not far from the amount of stress
many people go through in diverse predicaments in terms of NO generation when stress
is maximal. You need to. These might include preparing for an exam or a job interview
or stress as it relates to dangerous job situations like military operations or other stress-
inducing situations. The findings suggest that somewhere between 1 and 3 hrs, the ma
chinery in the PVN increases NO-producing activity at a remarkable rate compared to the
other time periods. The SON also showed an increase in NOS after the 3-hr time point.
However, compared to the PVN, the difference was not as sharp or severe. We see that
overall activity in the SON is not decreased after 6 hrs simply because there is a decrease
in NOS. Several neurons in the PVN show an increased amount of cells that are positive
for Fos but not for nNOS. This may mean that those numerous neurons are active and
are using another neurotransmitter instead of NO. The observation of this type of Fos-
immunoreactive cells during restraint stress seems to be in agreement with other studies
involving a similiar paradigm in other systems including the bed nucleus of stria termi-
nalis (BNST) and the amygdala,27'45 which suggest a continuous neural response after the
onset of psychological stress even after the initial response to acute stress. More studies
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are needed to delve further into the exact mechanisms that are taking place.
Additionally, to ascertain how a continued, isolated acute stress exposure influences
the equilibrium that exists, linking cell proliferation/differentiation and apoptosis. This
was accomplished through the comparing and analysis of pERKl/2 and CAD. The im-
munoreactivity pattern in a discrete circuit comprised of multiple nuclei which are collec
tively involved in organization of neural whole-organism response to a stressor suggests
functional synergy within this systemic circuit. All of the nuclei must work together to re
spond to stress and it is this cooperative function that helps to regulate the stress response.
Over time, different nuclei are more active than others. The activation seems to be dynam
ically altered. However, more studies are required to further understand the interaction
among the different components of the circuit during progressive exposure to stressful
stimuli.
The pERKl/2 immunoreactivity in the majority of the brain areas assayed was ob
served to be highest within 3 hrs of restraint, compared to lh, 6h, and unstrained animals.
Comprehensively, these observations suggest a specific stimulus activation of pERKl/2
in a discrete network of brain areas within the hypothalamic region as well as other ar
eas of the brain . In the hippocampus, for example, increased pERKl/2 immunoreactiv
ity was observed in all time periods compared to control animals. These area is involved
in the processing memories and learning. During this novel stress-inducing stimulation
32
exposure, the animals may be learning coping mechanisms and learning helplessness.
Moreover, we have observed more pERKl/2 immunoreactive cells in the sensory, as com
pared to the motor cortex, which implies that, because the animals are immobilized, the
motor cortex is not very active. However, even in an immobilized state, the rats are bom
barded with sensory input and are processing this information. In the amygdala, there is a
pERKl/2 immunoreactivity, which is not surprising given that the amygdala is involved in
fear and emotion.
In the cortex, especially the cingulate and motor cortices, there more processes, den-
drites, and fibers were observed to be intensely stained after 3 hrs of restraint exposure.
The same was observed in the NADPH-d stained sections of the SON. This suggests that
the network of communication between neurons and possibly different brain systems dis
plays progressive increases in complexity as the time of immobilization increases. This
could be because when there is an increase in NO release at the axon terminals. Which
means that there is more NO present locally, but also efferent projections are enhanced so
that signals are propagated more efficiently presumably to modulate the stress response.
The differences in activity at different time periods of stress exposure have different im
plications. For instance, at the 3 hr time period, other parts of the brain may also be in
volved so the connections with these other brain areas will be more active. Many of these
other areas contain NO-containing fibers. It is suggested by our observations that there
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En masse, these observations convey that there is preferential involvement of NO-
producing neurons in the PVN and SON in a time-dependent manner as a result of re
straint stress. The ambition for this research involved the development of an inclusive
elucidation of major spatio-temporal activation of neurons within distinct subregions
of the rat brain by acute restraint stress. To reveal neurons in the rat hypothalamus in
volved in responses to restraint stress, the distribution of Fos oncoprotein immuno reac
tivity was studied following restraint sessions of 1, 3, or 6 hrs compared to unrestrained
control animals. The neurochemistry of the stimulated neurons was investigated using
antibodies to Fos and nNOS and by histochemical localization of nicotinamide adenine
dinucleotide phosphate (NADPH) diaphorase. Co-localization of Fos and nNOS may tell
us that the neurons forming pathways within the hypothalamus, which are activated on
restraint stress, presumably mediating the stress response, may utilize NO as their trans
mitter substance yet others do not. More research is needed to identify and classify these
other neurotransmitters.
The implications for this field of study are massive and include but are not limited
to serving as a basis for helping to develop methods and pharmacology aimed at reducing
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and avoiding hyperactive stress responses. Many disorders have a basis in the body' over-
reaction to stressful situations. Advances in this field, including the present studies, may
aid in the diagnosis and treatment of such maladies. In conclusion, our observations sug
gest that as the time of stress exposure increases, there is increased NO immunoreactivity.
Because brain areas other than the PVN and SON contain NO-containing fibers, it may
be the case that there are more processes observed as the stress exposure time increases
because of increased communication between these areas. The network becomes more
complex and communication is facilitated to aid in the response to stress - all processes
likely modulated, at least in part, by NO.
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Figure A.2. Experimental Design
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Table A. 1. Data Table of co-localization of nNOS-, Fos-immunoreactive cells in the
SON. The table shows the mean number of neurons showing nNOS-immunoreactivity,
Fos-immunoreactivity, and both in the SON after exposure to restraint for 1, 3, and 6 hrs
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Figure A.3. Comparison of cells positive for NOS, as indicated by the presence of
NADPH-d, in the SON for non-restrained animals and animals restrained for an hour.
Magnification: 20x. NADPH-d, nicotinamide adenine dinucleotide phosphate diaphorase;
SON, supraoptic hypothalamic nucleus; PVN, paraventricular hypothalamic nucleus; V3,
third ventricle.
PVN
Figure A.4. Graphical representation of cells positive for NADPH-d (black bars), and
nNOS immunioreactive neurons (red bars) in the SON for non-restrained animals against
animals restrained for an hour. Magnification: 20x. NADPH-d, nicotinamide adenine
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Figure A.5. Graphical representation of cells positive for NADPH-d (black bars), and
nNOS immunioreactive neurons (red bars) in the PVN for non-restrained animals against
animals restrained for an hour. Magnification: 20x. NADPH-d, nicotinamide adenine
dinucleotide phosphate diaphorase, PVN, paraventricular hypothalamic nucleus.
Figure A.6. Comparison of cells positive for nNOS, as indicated by the red color (Texas
Red) in the SON and PVN for non-restrained animals (A,C) and animals restrained for an
hour (B,D). SON, supraoptic hypothalamic nucleus; PVN, paraventricular hypothalamic










Figure A.7. NADPH-d activity in the hypothalamus. The photomicrographs show the
alterations in the hypothalamic neuronal NOS-producing machinery after exposure to
restraint for 1-, 3-, and 6-hrs. (PVN - A,C,E,G respectively;B,D,F,H respectively). Magni
fication: 20x. PVN, paraventricular hypothalamic nucleus; and SON, supraoptic nucleus;
V3, third ventricle.
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Figure A.8. NADPH-d activity in the supraoptic nucleus. Mean number of NADPH-
d-positive neurons in the supraoptic nucleus of the hypothalamus. Magnification: 20x.
NADPH-d: nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase.
PVNNADPH-a-POSnWE CELLS
Figure A.9. NADPH-d activity in the PVN. Mean number of NADPH-d-positive neu
rons in the paraventricular nucleus of the hypothalamus. Magnification: 20x. NADPH-d:














Figure A. 10. Box and whisker plot of nNOS-immunoreactive cells in the SON. Shown
is a graphic representation of the mean number of nNOS-immunoreactive neurons in the
supraoptic nucleus of the hypothalamus. Magnification: 20x. SON, supraoptic nucleus.
MEAN NUMBER OF nNOS/cFOS-IR-























Table A.2. Data table representing co-localization of Fos-, nNOS-immunoreactive cells
in the PVN. The table shows the mean number of neurons per section with nNOS-, Fos-
immunoreactivity, and both in the PVN after exposure to restraint for 1, 3, and 6 hrs and
control animals. nNOS, neuronal nitric oxide synthase; PVN, paraventricular nucleus.
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Figure A. 11. nNOS-immunoreactivity in the SON. The photomicrographs show the vari
ation of nNOS-immunoreactivity in the hypothalamic SON topography after exposure to
restraint for 1 hr, 3 hr and 6 hr (B-D, respectively), versus control animals (A). Magnifica







Figure A. 12. Box and whisker plot of nNOS-immunoreactive cells in the PVN. Shown
is a graphic representation of the mean number of nNOS-immunoreactive neurons in the
paraventricular nucleus of the hypothalamus. Magnification: 20x.
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Figure A. 13. nNOS-immunoreactive cells in the PVN. The photomicrographs show the
variation of NOS and Fos-immunoreactivity in the hypothalamic PVN topography after
exposure to restraint for 1 hr, 3 hr and 6 hr(B-D, respectively), versus control animals
(A). Magnification: 20x. nNOS, neuronal nitric oxide synthase; and PVN, paraventricular
hypothalamic nucleus
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Figure A. 14. Box and whisker plot of Fos-immunoreactive cells in the SON. The chart
shows the mean observed Fos-immunoreactivity neurons in the SON. Magnification: 20x.
SON, supraoptic nucleus.
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Figure A. 15. Fos-immunoreactivity in the SON. The photomicrographs show the vari
ation of Fos-immunoreactivity in the hypothalamic SON topography after exposure to
restraint for 1 hr, 3 hr and 6 hr(B-D, respectively), versus control animals (A). Magnifica
tion: 20x. nNOS, neuronal nitric oxide synthase; and SON, supraoptic nucleus.
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Figure A. 16. nNOS-immunoreactivity in the PVN. The photomicrographs show the
variation of NOS and Fos-immunoreactivity in the hypothalamic PVN topography after
exposure to restraint for 1 hr, 3 hr and 6 hr(B-D, respectively), versus control animals
(A). Magnification: 20x. nNOS, neuronal nitric oxide synthase; and PVN, paraventricular
hypothalamic nucleus
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Figure A.17. Box and whisker plot of Fos-immunoreactive cells in the PVN.. The chart
shows the mean observed Fos-immunoreactive neurons in the PVN. Magnification: 20x.
PVN, paraventricular hypothalamic nucleus; and SON, supraoptic nucleus.
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Figure A. 18. co-localization of nNOS and of Fos -immunoreactivity in the SON. The
photomicrographs show the variation of NOS and Fos-immunoreactivity in the hypothala-
mic SON topography after exposure to restraint for 1 hr, 3 hr and 6 hr(B-D, respectively),
versus control animals (A). Magnification: 20x. nNOS, neuronal nitric oxide synthase;
and SON, supraoptic nucleus.
70
Figure A. 19. Co-localization of nNOS and Fos -immunoreactive cells in the PVN. The
photomicrographs show the variation of NOS and Fos immunoreactivity in the hypothala-
mic PVN topography after exposure to restraint for 1 hr, 3 hr and 6 hr (B-D, respectively),
versus control animals (A). Magnification: 20x. nNOS, neuronal nitric oxide synthase;
and PVN, paraventricular hypothalamic nucleus.
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Figure A.20. Fos-/nNOS-immunoreactive co-localized cells in the SON. The chart shows
the mean number of NOS-/Fos-immunoreactive neurons per section in the SON of the
hypothalamus. Magnification: 20x. SON, supraoptic nucleus.





Figure A.21. Colocalized Fos-/nNOS-immunoreactivity in the PVN. The chart shows the
mean number of NOS-/Fos-immunoreactive neurons in the PVN of the hypothalamus.
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Figure A.22. pERKl/2 (shown in green) and CAD (shown in red) immunoreactive cells in










Figure A.24. pERKl/2 immunoreactive cells in the amygdala. Magnification: 40x. ERK,
extracellular-signal-regulated kinase.
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Figure A.25. pERKl/2 immunoreactive cells in the sensory-motor cortex. Magnification:
left image: 20x; right images: 40x. ERK, extracellular-signal-regulated kinase.
Figure A.26. pERKl/2 immunoreactive cells in the cingulate cortex. Magnification: left
image: 20x; right image: 40x. ERK, extracellular-signal-regulated kinase.
